T cell senescence induced by DNMT1 deletion mediates cardiac transplant tolerance via altered CDKN1A methylation
Molecular Therapy · 2026-06 · 34 (6) · 3484-3502
DOI: 10.1016/j.ymthe.2026.02.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2026-06. Verfasst von Yuqi Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Heart Transplantation, DNA (Cytosine-5-)-Methyltransferase 1, DNA Methylation, Cyclin-Dependent Kinase Inhibitor p21. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Hubei Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
This study investigates the role of DNA methyltransferase 1 (DNMT1) in T cell senescence and heart transplant rejection using mouse models and clinical data. In the mouse heart transplantation model, DNMT1 was found to be highly expressed in graft-infiltrating T cells. Using Dnmt1flox/floxCd4cre/+ mice, researchers demonstrated that T cell-specific knockout of DNMT1 led to long-term graft survival by impairing effector differentiation and promoting senescence in CD4+ T cells rather than in CD8+ T cells. Whole-genome methylation sequencing and RNA sequencing revealed that DNMT1 knockout decreased methylation of the cyclin-dependent kinase inhibitor 1A (CDKN1A) promoter, upregulating CDKN1A expression. Depletion of CDKN1Ahigh cells reversed DNMT1-inhibitor-induced T cell senescence. Clinically, increased T cell senescence was observed in post-transplant patients and is known to increase with age. Additionally, data from the UNOS database showed lower rejection rates in older recipients (age >65). These findings suggest that DNMT1 ablation accelerates CD4+ T cell senescence by altering CDKN1A methylation, thereby reducing T cell function and mitigating rejection. DNMT1 may thus serve as a potential therapeutic target for heart transplant rejection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: 501308843@qq.com.
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: 1986xh0694@hust.edu.cn.
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laborato…
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Hubei Province
- National Natural Science Foundation of China
Zitieren
APA
Chen, Y., Yim, W. Y., Li, C., Wang, Z., Hou, J., Peng, Y., Liu, F., Liu, Z., Dong, N., & Wang, Y. (2026). T cell senescence induced by DNMT1 deletion mediates cardiac transplant tolerance via altered CDKN1A methylation. Molecular Therapy, 34(6), 3484-3502. https://doi.org/10.1016/j.ymthe.2026.02.015
Vancouver
Chen Y, Yim WY, Li C, Wang Z, Hou J, Peng Y, et al. T cell senescence induced by DNMT1 deletion mediates cardiac transplant tolerance via altered CDKN1A methylation. Molecular Therapy. 2026;34(6):3484-3502. doi:10.1016/j.ymthe.2026.02.015
BibTeX
@article{Chen2026,
author = {Chen, Yuqi and Yim, Wai Yen and Li, Chenghao and Wang, Zihao and Hou, Jincheng and Peng, Yongbu and Liu, Fayuan and Liu, Zongtao and Dong, Nianguo and Wang, Yixuan},
title = {T cell senescence induced by DNMT1 deletion mediates cardiac transplant tolerance via altered CDKN1A methylation},
journal = {Molecular Therapy},
year = {2026},
volume = {34},
number = {6},
pages = {3484--3502},
doi = {10.1016/j.ymthe.2026.02.015}
}
EUVIMED